Roe-051 Review

The advent of synthetic biology in the early 2010s introduced a paradigm shift: engineered microbes can be programmed to express tailor‑made enzymatic pathways, enhancing both speed and selectivity. Notable milestones—such as the Pseudomonas putida strains engineered for toluene degradation (2015) and the Escherichia coli chassis for arsenic sequestration (2018)—demonstrated the feasibility of this approach but also highlighted challenges in , genetic stability , and regulatory acceptance .

In the United States, the framework requires a rigorous risk assessment, including horizontal gene transfer (HGT) analysis. Roe‑051’s design, with multiple containment layers, aligns with the “Containment‑by‑Design” principles advocated by the National Academies. Internationally, the Cartagena Protocol on Biosafety will influence cross‑border deployments, prompting the need for harmonized standards. roe-051